¹B°Ê¥Í²z¾Çºô¯¸ ·|­û¡G¥¼µn¿ý¡@µn¤J¡@§Ñ°O±K½X¡@¥Ó½Ð¥[¤J·|­û ¡@·|­û9727 ¡@³¡¸¨®æ5¡@¡@




¥DÃD¡G¦p¦ó¥¿½T¨Ï¥Î¦Ù»Ä??
µo¨¥ : dyson ®É¶¡ : 02/08/16(19:23:41) From : 61.229.196.159
¦p¦ó¥¿½T¨Ï¥Î¦Ù»Ä??


¦^À³ : 5 scwang®É¶¡ : 2003/4/25 ¤U¤È 09:43:29 From : 140.123.5.19

kay [¤k][¾Ç¥Í]

§Ú¬O¤@­Ó¿ï¤â,ªø´Áªº¨Ï¥Î¦Ù»Ä·|¦³¤°»ò¤Ï®ÄªG¶Ü??¦h¤Öªº¥Î¶q¬O³Ì«ê·íªº??ÁÙ¦³ªA¥Îªº®É¾÷??~~~~ÁÂÁÂ


Normalin¦^À³¡G
¦Ù»Ä¬O¤@°Ó«~
À³¸Ó¬Ý¼Ð¥ÜªA¥Î
¦pªG³s¼Ð¥Ü³£¨S¦³
¤£¥Î¤]§a
§ï¥Î¦³¼Ð¥Üªº
­^¤å¤£À´®É½Ð¥L¤H¸ÑÄÀ
¾Ú§Ú©Òª¾
¦X²z¨Ï¥Î°Æ§@¥Î¦n¹³«Ü¤Ö©Î´X¥G¨S¦³

normalin¦^À³¡G
¹L¥h
´¿¸gµo²{¦Ù»Ä¤§¤¤¦³¹B°Ê¸TÃÄ
¦]¦¹¼tµP¬Û·í­«­n


¦^À³ : 6 Âà¶K®É¶¡ : 2004/7/25 ¤U¤È 01:34:47 From : 219.71.65.212

¤pªL¸ß°Ý¦p¤U¡G

±z¦n¡G
·Q½Ð°Ý¤@¤U¡A±M·~¹B°Ê­ûªA¥Î¦Ù»ÄÀ°§U­«¶q°V½m¡A¯h³Òªºª¬ªpªº½T¦³§ïµ½¡A¦Ù¦×¤]¼Wªø¼W±j¤£¤Ö¡C¥Ø«e¬O¨ÌªA¥Î¦Ù»Ä¼t°Ó´£¨Ñ¤§«ü¾É¡A¤£ª¾©|¦³¦ó»Ýª`·N¤§³B¡H¬O§_·|²£¥Í°Æ§@¥Î©Î¨ä¥L¡H¤S¡A²{¦b¥«­±¤Wªº¦Ù»Ä¥H¦ó¼tµP¸û¨Î¡A½Ðµ¹¤©«ØÄ³¡AÁÂÁ¡C


1.³sÄò 6¤Ñ¡B¨C¤Ñ20§JªºcreatineÄá¨ú¡A¹ï©ó­@¤O¹B°Êªí²{¦³­t­±ªº¼vÅT¡C³q±`¦b3¦Ü5¤ÀÄÁ¥H¤ºªº³Ì¤j¹B°Êªí²{¡A¬Ò·|¦]¬°creatineªº¾A·íÄá¨ú¦Ó¦³ÅãµÛªº¼W¶i¡A¦ý¬O¨Ã¤£¬O¥þ³¡ªº¬ã¨s³ø§i¬Ò¤ä«ù¡C
2.Journal of the American College of Nutrition,17(3):216-234¡C¤@½greview¬ã¨s³ø§i¤¤«ü¥X¡A¦b 8¶gªºcreatineÄá¨ú¤U¡A¨Ã¤£·|¦³°·±d¤Wªº¦MÀI¡A¦ý¬O¶W¹L8 ¶g¥H¤WªºÄá¨úª¬ªp¡A«h¤´¨S¦³§¹¾ãªº¬ã¨s³ø§i¡Ccreatine¨Ï¥ÎªÌ¡A¦ü¥GÀ³¸Ó¦b2 ­Ó¤ëªºÄá¨ú«á¡A¶¡Â_ªA¥Î¤@¬q®É¶¡¡C

3.¦~ÄÖ¤£¦P·|¦³¤£¦PªºªA¥Î®ÄªG¡C³q±`¡A¤¤¦~50·³¥ª¥kªºªA¥Î®ÄªGÀu©ó¦~»´¤H (30·³)¡CJournal of Applied Physiology,85(4):1349-1356.


±z¦n¡G
ÁÂÁ«e¤@¦¸ªº¦^ÂСC¦ý§Ú¦³¤@¨Ç¤£©úÁA¤§³B¡G
1.±z©Ò»¡¡u 6¤Ñ¡A¨C¤Ñ20§JªºcreatineÄá¨ú¹ï©ó­@¤O¹B°Êªí²{¦³­t­±ªº¼vÅT¡v¡A·N«ä¬O¡A¦¹¥Î¶q¥Îªk·|¦³¼vÅT¡A¬O¸Ó§ïÅܥΪkÁÙ¬O¨ä¥Lªº·N«ä¡H
2.¡u3¦Ü5¤ÀÄÁ¥H¤ºªº³Ì¤j¹B°Êªí²{¡A¬Ò·|¦]¬°Creatineªº¾A·íÄá¨ú¦Ó¦³ÅãµÛªº¼W¶i¡C¡v±q¨Æ´Î²y¹B°Ê¡A¦Ó·PıÃzµo¤O¦ü¥G¦³¼W¥[¡]³o¤]¬OªA¥Îªº¥D­n¥Øªº¡^¡A¬O¥¿±`ªº¤ÏÀ³¶Ü¡H
3.25·³ªºªA¥ÎªÌ·|¦³¦óºØ®ÄªG¡H³Ì«áÁÙ¬O³Â·Ð±z«ØÄ³¤@¤U¡A¦]¬°¤£ª¾²{¦bªA¥Î¼tµPªº¦nÃa©Î¾A¦X»P§_
ÁÂÁ¡I


½Ð°Ñ¦Ò¥H¤U¸ê®Æ

1.³¯«Ø¾±¡B¾¤«T«Û(1998)¡G¤fªA¦Ù»Ä¸É¥R¹ïµL®ñ¹B°Êªí²{ªº¼vÅT¡A¤¤µØÅé¨|¡A43´Á¡A­¶½X¤£ª¾¡A¤¤µØ¥Á°êÅé¨|¾Ç·|(¥»ºô¯¸¼ö½u³sµ²¤¤)¡C

2.Guerrero-O,ML & Wallimann,T (1998) Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo : down-regulation of the expression of creatine transporter isoforms in skeletal muscle. Molecular & Cellular Biochemistry,184(1-2):427-437.

3.Engelhardt,M Neumann,G Berbalk,A & Reuter,I (1998) Creatinine supplementation in endurance sports. Medicine & Science in Sports & Exercise,30(7):1123-1129.

4.McNaughton,LR Dalton,B & Tarr,J (1998) The effects of creatine supplementation on high-intensity exercise performance in elite performers. European Journal of Applied Physiology & Occupational Physiology,78(3):236-240.

5.Williams,MH & Branch,JD (1998) Creatine supplementaion and exercise performance : an update. Journal of the American College of Nutrition,17(3):216-234.


§A¤]¥i¥H¥ÑÂåÃĽå͸ê°Tºô¯¸¤¤§ä¨ì¬ÛÃö¸ê®ÆªººK­n¡C

**°ê¥~´¿¦³¬ã¨s³ø§iµo²{¡AªA¥Î¦H½èªº¦Ù»Ä³y¦¨¦º¤`ªº­t§@¥Î¡A¬ÛÃö¸ê®Æ½Ð»PÀç¾i±M®a½Ð±Ð (¨Ò¦p¡G¹B°ÊÀç¾i¶g°Tªº±i®¶±^¥ý¥Í¡A¥»ºô¯¸ªººô¸ôªÚ¾F³sµ²¤¤)¡C


¦^À³ : 7 ªü¤å®É¶¡ : 2005/5/8 ¤U¤È 09:06:58 From : 219.71.70.137

¥DÃD¡G®ò¦Ù»Ä©Î¦Ù»Ä±a¨Óªº°Æ°µ¥Î

µo¨¥ : ªü¤å ®É¶¡ : 05/05/08(17:41:12) From : 220.133.194.130¦pÃD¡@¬O¹B°Êªº¤H³£¤§¹D¡@¡@¨Ï¥Î¾A·íªºÀç¾i«~¥iÃD´£¤É¦¨¿n
¦ý¬O¦p¦óª`·N©l¥Î¶q©M¤£¯àªø´Á¶¡ªA¥Î¡@¦p¦Ù»ÄÁöµM¹ï´£¤É¦¨ÁZ¦³¤£
¿ùªº¼vÅT¡@¦ý¹³³oºØªF¦èÄá¨ú®É¶¡¤ô­n¦h³ÜÅý¥¦¥NÁ¡@¤]¤£¯àªø´ÁªA¥Î©È¹ïµÇ©Î¨xªº°Æ²ü¤Ó¤j¡@¡@·Q½Ð°ÝÀç¾i¤è­±ªº±M®a¹³ªA¥Î¾b®ò¦Ù»Ä¤]·|¦³³o¼Ëªº°ÝÃD¹À¡@¦]¬°¥¦ÁöµM¥«¤HÅ饲»Ý¦ý¤£¤§¤]§_¦³¦p®V»Ä¤è­±ªº°ÝÃD



¦@¦³ 7 ¦^À³ ¡@¡@¦^¤W­¶ ¡@¡@µoªí¦^À³
 B ʥͲz Ǻ
 B ʥͲz Ǻ     Ǥƶ] B V m
 B ʥͲz Ǻ    x W   a V m A ȥ  x
 B ʥͲz Ǻ      Z w   P V m B
    (PFQ) [ c
 B ʥͲz Ǻ    C ֦~    פ  R
 B ʥͲz Ǻ   YouTube W D
¤ßªÍ¾A¯à°V½mªº²z½×»P¹ê»Ú

epsport-ad

 j M     ҾǥZ

¹B°Ê¥Í²z¾Çºô¯¸¯»µ·¹Î
¹B°Ê¬ì¾Ç±Ð¨|¬ã¨s«Ç